Samrat Pharmachem Closes Trading Window for Q1 FY27 Results

Samrat Pharmachem Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended June 30, 2026. During this period, insiders are prohibited from trading in the company's shares, especially if they possess Unpublished Price Sensitive Information.